J&J Subsidiary Scores Another Victory In Stent Case

Law360, New York (March 17, 2006, 12:00 AM EST) -- The U.S. Court of Appeals for the Federal Circuit has affirmed a lower court’s ruling to not reconsider a claim by Arlaine & Gina Rockey Inc., which holds certain patents on stent technology, asserting that Johnson & Johnson subsidiary Cordis Corp. owes royalties under the companies’ licensing agreement.

In the late 1970s, after experimenting with methods of treating problems with blood vessels and the gastrointestinal tract, Dr. Arthur G. Rockey obtained what are known as “the Rockey patents,” which cover various medical devices and procedures involving...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.